Thrombocytopenia: FDA reporting patterns
110,021 FDA FAERS reports mention Thrombocytopenia. 106,151 reports have a serious outcome flag.
Medicines named as suspect
- Dexamethasone: 7,098 reports
- Lenalidomide: 6,451 reports
- Cyclophosphamide: 6,127 reports
- Rituximab: 6,108 reports
- Carboplatin: 5,689 reports
- Doxorubicin: 4,741 reports
- Methotrexate: 4,606 reports
- Gemcitabine: 4,318 reports
- Etoposide: 3,907 reports
- Vincristine: 3,721 reports
- Oxaliplatin: 3,704 reports
- Cisplatin: 3,531 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.